Major shareholder announcement

June 21, 2024

Company announcement No. 22

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that Novo Nordisk Fonden has on its own behalf and on behalf of its wholly owned subsidiary Novo Holdings A/S notified Novonesis, that as of yesterday, Novo Nordisk Fonden and Novo Holdings A/S, indirectly and directly, respectively, holds a total of 53,743,600 A-shares (nominally DKK 107,487,200) and 65,672,555 B-shares (nominally DKK 131,345,110) corresponding to 25.50% of the entire issued share capital and 63.35% of the total voting rights in Novozymes A/S, part of Novonesis Group.

Attachment

• 2024_22_Major_Shareholders_Announcement

You May Also Be Interested In

• Iveco Group 2026 Second Quarter Results
• Arcadis Q2 and Half Year 2026 Results: Strong momentum for the next phase of profitable growth. Strategic targets in place for 2027-2029
• Bekaert: 2026 Half Year Results